Idioma:

Exploring breast cancer exosomes for novel biomarkers of potential diagnostic and prognostic importance

Alagundagi, Dhananjay B. ; Ghate, Sudeep D. ; Rajendra, Vinay Kumar J. ; Gollapalli, Pavan ; Shetty, Vijith V. ; D’Souza, Caren ; Shetty, Praveenkumar ; Patil, Prakash

3 Biotech, 2023-01, Vol.13 (1), p.7-7, Article 7 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por

Enviar para

Título:
Exploring breast cancer exosomes for novel biomarkers of potential diagnostic and prognostic importance
Autor: Alagundagi, Dhananjay B. ; Ghate, Sudeep D. ; Rajendra, Vinay Kumar J. ; Gollapalli, Pavan ; Shetty, Vijith V. ; D’Souza, Caren ; Shetty, Praveenkumar ; Patil, Prakash
Assuntos: Adenocarcinoma ; Agriculture ; Anticancer properties ; Antitumor agents ; Bioinformatics ; Biomarkers ; Biomaterials ; Biotechnology ; Breast cancer ; Cancer Research ; Chemistry ; Chemistry and Materials Science ; Exosomes ; Genes ; Hsp90 protein ; Lipids ; Medical diagnosis ; Medical prognosis ; Nucleic acids ; Original ; Original Article ; Patients ; Proteins ; Reagents ; Stem Cells ; Telomerase
É parte de: 3 Biotech, 2023-01, Vol.13 (1), p.7-7, Article 7
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: The comprehensive bioinformatics analysis of breast cancer exosomes revealed that HSP90AA1, CCT2, and ENO1 were novel hub genes in the giant protein–protein interaction network of 110 exosomal proteins. Exosomes and their cargo such as discrete proteins, nucleic acids, and lipids are having potential role in the pathophysiology of breast cancer (BC). This study showed that the identified hub genes were particularly abundant in GO and KEGG pathways relevant to the positive regulation of telomerase. In addition, these hub genes were found to be considerably overexpressed in breast adenocarcinoma patients compared to healthy controls, and further, this overexpression is linked to the poor prognosis in BC patients. Furthermore, the ROC analysis revealed that CCT2 gene has strong diagnostic and prognostic value for BC. Additionally, this in silico analysis found that the anticancer agents and HSP90 inhibitors such as ganetespib, retaspimycin, and tanespimycin would have considerable potential in the treatment of BC. Overall, this study findings imply that HSP90AA1, a molecular chaperon and CCT2, a chaperonin would serve as diagnostic and prognostic biomarkers, respectively, for BC. However, these findings need to be further confirmed by laboratory and clinical studies for validating their potential applications.
Editor: Cham: Springer International Publishing
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 7 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Exploring breast cancer exosomes for novel biomarkers of potential diagnostic and prognostic importance

Alagundagi, Dhananjay B. ; Ghate, Sudeep D. ; Rajendra, Vinay Kumar J. ; Gollapalli, Pavan ; Shetty, Vijith V. ; D’Souza, Caren ; Shetty, Praveenkumar ; Patil, Prakash

Cham: Springer International Publishing

Buscando em bases de dados remotas. Favor aguardar.